US7144496B2ExpiredUtilityA1

Biological fluid analysis device

93
Assignee: PALL CORPPriority: Nov 2, 2000Filed: Nov 2, 2001Granted: Dec 5, 2006
Est. expiryNov 2, 2020(expired)· nominal 20-yr term from priority
C12Q 1/001
93
PatentIndex Score
187
Cited by
56
References
26
Claims

Abstract

A biological fluid analysis device ( 100 ) including a biosensor ( 50 ) comprising an electrochemical-enzymatic sensor including a working electrode ( 51 ) and a reference electrode ( 52 ), is disclosed.

Claims

exact text as granted — not AI-modified
1. A biological fluid analysis device comprising:
 a housing including a biological fluid analysis chamber suitable for receiving a plasma-containing portion of biological fluid; 
 a vent communicating with the analysis chamber, the vent comprising a porous medium having a bacterial blocking pore rating; and 
 a biosensor communicating with the analysis chamber, the biosensor comprising an electrochemical-enzymatic sensor including a working electrode and a reference electrode, wherein the biosensor is arranged to monitor oxygen concentration in the analysis chamber over at least about a 4 hour time period; and 
 at least one visible marker that is activated while a change in oxygen concentration is monitored. 
 
     
     
       2. The device of  claim 1 , wherein the biosensor includes laccase. 
     
     
       3. The device of  claim 1 , including a self-contained power source. 
     
     
       4. The device of  claim 3 , wherein the first visible marker comprises a first indicator lamp that is activated when the oxygen concentration is monitored, the device further comprising at least a second indicator lamp that is either activated when, within a predetermined period of time, a decrease in oxygen concentration reaches a preset reference or threshold value, or the oxygen concentration does not reach a preset reference or threshold value. 
     
     
       5. The device  claim 1 , further comprising a heater arranged to raise the temperature of the plasma-containing fluid in the chamber over the ambient temperature for a desired period of time. 
     
     
       6. The device of  claim 1 , wherein the analysis chamber has an internal volume suitable for receiving about 10 ml of biological fluid or less. 
     
     
       7. The device of  claim 6 , wherein the internal volume is suitable for receiving about 2 to about 5 ml of biological fluid. 
     
     
       8. The device of  claim 1 , wherein the analysis chamber contains sodium polyanethol sulfonate. 
     
     
       9. A biological fluid analysis device comprising:
 a housing including a biological fluid analysis chamber suitable for receiving a plasma-containing portion of biological fluid; 
 a vent communicating with the analysis chamber, the vent comprising a porous medium having a bacterial blocking pore rating; and 
 a biosensor communicating with the analysis chamber, the biosensor comprising an electrochemical-enzymatic sensor including a working electrode and a reference electrode, wherein the biosensor includes laccase and is arranged to detect oxygen concentration in the analysis chamber; 
 further comprising a flexible blood bag in fluid communication with the biological fluid analysis device. 
 
     
     
       10. The device of  claim 9 , arranged to monitor the oxygen concentration in the analysis chamber over a period of time. 
     
     
       11. The device of  claim 10 , arranged to monitor the oxygen concentration in the analysis chamber over at least about a 4 hour period of time. 
     
     
       12. The device of  claim 11 , further comprising at least one visible marker that is activated while the oxygen concentration is monitored. 
     
     
       13. The device of  claim 9 , arranged to detect a change in the oxygen concentration over at least about a 4 hour period of time. 
     
     
       14. The device of  claim 13 , further comprising at least one visible marker that is activated while a change in oxygen concentration is monitored. 
     
     
       15. The device of  claim 9 , further comprising at least a second visible marker that is activated when a decrease in oxygen concentration reaches a preset reference or threshold value. 
     
     
       16. The device of  claim 9 , comprising a first indicator lamp that is activated when the oxygen concentration is monitored, and at least a second indicator lamp that is activated when a decrease in oxygen concentration reaches a preset reference or threshold value. 
     
     
       17. The device of  claim 16 , wherein the first indicator lamp has a different visible wavelength than the second indicator lamp. 
     
     
       18. The device of  claim 9 , further comprising a heater arranged to raise the temperature of the plasma-containing fluid in the chamber over the ambient temperature for a desired period of time. 
     
     
       19. The device of  claim 18 , wherein the heater includes a thermistor. 
     
     
       20. The device of  claim 18 , wherein the heater includes a conductive trace. 
     
     
       21. A method for processing a biological fluid comprising:
 passing a portion of a biological fluid into an analysis chamber of a biological fluid analysis device comprising: a housing including a biological fluid analysis chamber suitable for receiving a plasma-containing portion of biological fluid; a vent communicating with the analysis chamber, the vent comprising a porous medium having a bacterial blocking pore rating: and a biosensor communicating with the analysis chamber, the biosensor comprising an electrochemical-enzymatic sensor including a working electrode and a reference electrode, wherein the biosensor is arranged to monitor oxygen concentration in the analysis chamber; 
 detecting the oxygen concentration in the analysis chamber; 
 activating a first indicator lamp when a change in oxygen concentration is monitored; and 
 activating at least a second indicator lamp when a decrease in the oxygen concentration reaches a preset reference value. 
 
     
     
       22. The method of  claim 21 , including monitoring the oxygen concentration in the analysis chamber over at least about a 4 hour period of time. 
     
     
       23. The method of  claim 21 , including monitoring a change in the oxygen concentration in the analysis chamber over at least about a 6 hour period of time. 
     
     
       24. The method of  claim 21 , including raising the temperature of the biological fluid in the analysis chamber to at least about 30° C. for at least about 6 hours. 
     
     
       25. The method of  claim 21 , including passing the portion of biological fluid through a filter that allows microorganisms to pass through while depleting the fluid of at least one of leukocytes, red blood cells and platelets, before passing the portion of biological fluid into the analysis chamber. 
     
     
       26. A biological fluid analysis device comprising:
 a housing including a biological fluid analysis chamber suitable for receiving a plasma-containing portion of biological fluid; 
 a vent communicating with the analysis chamber, the vent comprising a porous medium having a bacterial blocking pore rating; and 
 a biosensor communicating with the analysis chamber, the biosensor comprising an electrochemical-enzymatic sensor including a working electrode and a reference electrode, wherein the biosensor is arranged to monitor oxygen concentration in the analysis chamber over at least about a 4 hour period of time; and 
 at least one visible market that is activated while the oxygen concentration is monitored.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.